Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2

Biochim Biophys Acta. 2016 Jul;1858(7 Pt A):1488-98. doi: 10.1016/j.bbamem.2016.04.003. Epub 2016 Apr 8.

Abstract

Recently, several peptides have been studied regarding the defence process against pathogenic microorganisms, which are able to act against different targets, with the purpose of developing novel bioactive compounds. The present work focuses on the structural and functional evaluation of the palindromic antimicrobial peptide Pa-MAP2, designed based on the peptide Pa-MAP from Pleuronectes americanus. For a better structural understanding, molecular modelling analyses were carried out, together with molecular dynamics and circular dichroism, in different media. Antibacterial activity against Gram-negative and positive bacteria was evaluated, as well as cytotoxicity against human erythrocytes, RAW 264.7, Vero and L6 cells. In silico docking experiments, lipid vesicle studies, and atomic force microscopy (AFM) imaging were carried out to explore the activity of the peptide. In vivo studies on infected mice were also done. The palindromic primary sequence favoured an α-helix structure that was pH dependent, only present on alkaline environment, with dynamic N- and C-terminals that are stabilized in anionic media. Pa-MAP2 only showed activity against Gram-negative bacteria, with a MIC of 3.2 μM, and without any cytotoxic effect. In silico, lipid vesicles and AFM studies confirm the preference for anionic lipids (POPG, POPS, DPPE, DPPG and LPS), with the positively charged lysine residues being essential for the initial electrostatic interaction. In vivo studies showed that Pa-MAP2 increases to 100% the survival rate of mice infected with Escherichia coli. Data here reported indicated that palindromic Pa-MAP2 could be an alternative candidate for use in therapeutics against Gram-negative bacterial infections.

Keywords: Molecular dynamics; Pa-MAP2; Pleuronectes americanus; Secondary structure; Synthetic palindromic peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine / chemistry
  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Antimicrobial Cationic Peptides / chemistry*
  • Antimicrobial Cationic Peptides / isolation & purification
  • Cell Survival / drug effects
  • Chlorocebus aethiops
  • Cholesterol / chemistry
  • Erythrocytes / drug effects
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Escherichia coli Infections / drug therapy*
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / mortality
  • Flounder / metabolism
  • Humans
  • Lipopolysaccharides / chemistry
  • Mice
  • Molecular Dynamics Simulation
  • Molecular Sequence Data
  • Peptidomimetics / chemical synthesis
  • Peptidomimetics / chemistry*
  • Peptidomimetics / pharmacology
  • Phosphatidylcholines / chemistry
  • Phosphatidylglycerols / chemistry
  • Phosphatidylserines / chemistry
  • Protein Structure, Secondary
  • Protein Structure, Tertiary
  • Survival Analysis
  • Unilamellar Liposomes / chemistry
  • Vero Cells

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Lipopolysaccharides
  • Peptidomimetics
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • Phosphatidylserines
  • Unilamellar Liposomes
  • 1-palmitoyl-2-oleoylglycero-3-phosphoserine
  • 1-palmitoyl-2-oleoylglycero-3-phosphoglycerol
  • Cholesterol
  • Alanine
  • 1-palmitoyl-2-oleoylphosphatidylcholine